NGFR inhibitor
Catalog No. N28-909B
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
N28-909B-05 | 5 mg | $90 | |
N28-909B-25 | 25 mg | $450 | |
N28-909B-BULK | BULK | Contact Us |
Overview:
Inhibits NGF receptor tyrosine kinase (TrkA, pp140trk) . Inhibits NGF-induced neurite outgrowth in PC12 cells (1). Displays antitumor activity in a mouse model (2). Blocks the ETK-PAK1 interaction, suppressing RAS-induced PAK1 activation and malignant transformation (3). Cell permeable.
References:
1. M Ohmichi et al. Biochemistry 1993 32:4650
2. M Rende et al. Anticancer Drugs 2006 17:929
3. H He et al. Cancer Biol. Ther. 2004 3:96
CAS Registry Number:
148741-30-4
Molecular Formula:
C18H24N2OS
Appearance:
Yellow powder
Melting Point:
223-224o C
Molecular Weight:
316.5
Purity:
>99% (TLC); NMR (Conforms)
Solubilization:
May be dissolved in DMSO (25mg/ml) or Ethanol (20 mg/ml)
Aliases:
alpha-Cyano-(3,5-di-t-butyl-4-hydroxy)thiocinnamide
Storage and Stability:
Store desiccated as supplied at -20oC for up to 2 years. Store solutions at -20oC for up to 2 months.
Molecular Structure:
There are no related publications available for this product.
AKT/PKB Pathway, Angiogenesis, Apoptosis/Autophagy, Cancer, Cardiovascular Disease, Cell Cycle, ERK/MAPK Pathway, Inflammation, Invasion/Metastasis, Metabolic Disorder, Neurobiology, PKA/PKC Pathway, Receptor Tyrosine Kinases
STAY CONNECTED
Fax: 1-604-232-4601